Skip to content
OpenCapital
Get started

Next Technology Holding NXTT Acquired in-process research and development

Acquired in-process research and development at other companies

CTO
Citius Oncology, Inc.CTOR
$40M+2,393%
MAG
MagneraMAGN
$5M+53.8%
Smith & Wesson Brands, Inc. logo
Smith & Wesson Brands, Inc.SWBI
$0—
NVE Corporation logo
NVE CorporationNVEC
$771.2K-25.8%
Erasca, Inc. logo
Erasca, Inc.ERAS
$150M—
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$8.09M-32.3%

Segments

By segment

See full
CODM$2.12M—

Other financials

Income statement

See full
Revenue$465.2K—
Gross profit$77.9K—
Operating income-$6.6M-1,375%
Net income-$105.9M-155%
EPS (diluted)-$11.86-103%

Balance sheet

See full
Cash & equivalents$668.4K0.0%
Total debt$575.6K—
Total equity$510.9M+21.3%
Total assets$551.2M+13.9%

Cash flow

See full
Operating cash flow-$1.4M—
CapEx--100%
Free cash flow-$552.7K-110%

Valuation

See full
Market cap$84.65M-89.7%
Enterprise value$84.56M-89.7%
P/E0.5×—
P/S6.8×+4.0×

Profitability

See full
Gross margin59.4%+0.5pp
Operating margin-180.8%—
Net margin1,196.8%—
FCF margin-438.9%-453pp

Returns & leverage

See full
Return on equity93.2%—
Debt / equity0×—
Current ratio180.9×+27.0×

Where this comes from

Reported directly by Next Technology Holding in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Next Technology Holding’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Next Technology Holding's acquired in-process research and development.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Next Technology Holding's acquired in-process research and development?
Next Technology Holding (NXTT) reported acquired in-process research and development of $2.12M in Q1 2026.
How has Next Technology Holding's acquired in-process research and development changed year-over-year?
Next Technology Holding's acquired in-process research and development decreased by 41.4% year-over-year, from $3.62M to $2.12M.
What does acquired in-process research and development mean?
Represents the cash expenditure for research and development projects acquired through business combinations that have not yet reached technological feasibility. This highlights the company's strategy for inorganic growth and future innovation pipeline expansion.